Extend Medicare's prescription drug out-of-pocket cap and insulin cap to people with private insurance.

Extend Medicare’s $2,000 annual prescription drug out-of-pocket cap—rising to $2,100 in 2026 under the Inflation Reduction Act (P.L. 117-169)—and its $35 monthly insulin cap to individuals with private insurance.

The plan commits to extending Medicare drug and insulin caps to privately insured people.

Rep. Cisneros Unveils Health Care Action Plan | Representative Gil Cisneros
primary · press_release · model gpt-5.4-mini